Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association - PubMed (original) (raw)

Practice Guideline

. 2009 Jan 20;119(2):351-7.

doi: 10.1161/CIRCULATIONAHA.108.191305. Epub 2008 Dec 17.

Affiliations

• PMID: 19095622
• DOI: 10.1161/CIRCULATIONAHA.108.191305

Practice Guideline

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association

Jay S Skyler et al. Circulation. 2009.

Erratum in

• Circulation. 2009 Jun 30;119(25):e605

No abstract available

PubMed Disclaimer

Similar articles

• Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
  Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Skyler JS, et al. J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. doi: 10.1016/j.jacc.2008.10.008. J Am Coll Cardiol. 2009. PMID: 19147051 Review. No abstract available.
• Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
  Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Skyler JS, et al. Diabetes Care. 2009 Jan;32(1):187-92. doi: 10.2337/dc08-9026. Epub 2008 Dec 17. Diabetes Care. 2009. PMID: 19092168 Free PMC article. No abstract available.
• Implications of intensive glycemic control on cardiovascular disease: early reports from the ACCORD and ADVANCE Trials.
  Soo Yeon S, Nesto RW. Soo Yeon S, et al. Rev Cardiovasc Med. 2008 Winter;9(1):1-4. Rev Cardiovasc Med. 2008. PMID: 18418304 Review. No abstract available.

Cited by

• Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy.
  Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, Zhang Y, Shen S, Tong N. Lu X, et al. Signal Transduct Target Ther. 2024 Oct 2;9(1):262. doi: 10.1038/s41392-024-01951-9. Signal Transduct Target Ther. 2024. PMID: 39353925 Free PMC article. Review.
• Evaluation of Red Blood Cell Indices for Prediction of Glycemic Control in People Living with Type 2 Diabetes.
  Meshesha MD, Melke A, Ajema AT, Mayisso K. Meshesha MD, et al. Diabetes Metab Syndr Obes. 2024 Feb 7;17:619-632. doi: 10.2147/DMSO.S445331. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38343581 Free PMC article.
• Aortic Regurgitation: Review of the Diagnostic Criteria and the Management Guidelines.
  Malahfji M, Saeed M, Zoghbi WA. Malahfji M, et al. Curr Cardiol Rep. 2023 Oct;25(10):1373-1380. doi: 10.1007/s11886-023-01955-x. Epub 2023 Sep 16. Curr Cardiol Rep. 2023. PMID: 37715804 Review.
• Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy.
  Urbano F, Farella I, Brunetti G, Faienza MF. Urbano F, et al. Int J Mol Sci. 2023 Jul 26;24(15):11980. doi: 10.3390/ijms241511980. Int J Mol Sci. 2023. PMID: 37569354 Free PMC article. Review.
• Metformin Monotherapy Alters the Human Plasma Lipidome Independent of Clinical Markers of Glycemic Control and Cardiovascular Disease Risk in a Type 2 Diabetes Clinical Cohort.
  Wancewicz B, Zhu Y, Fenske RJ, Weeks AM, Wenger K, Pabich S, Daniels M, Punt M, Nall R, Peter DC, Brasier A, Cox ED, Davis DB, Ge Y, Kimple ME. Wancewicz B, et al. J Pharmacol Exp Ther. 2023 Aug;386(2):169-180. doi: 10.1124/jpet.122.001493. Epub 2023 Mar 14. J Pharmacol Exp Ther. 2023. PMID: 36918276 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information